Ignite Creation Date:
2024-05-06 @ 7:16 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02504892
Status:
TERMINATED
Last Update Posted:
2019-03-22
First Post:
2015-07-21
Brief Title:
Everolimus Therapy in People With Birt-Hogg-Dube Syndrome BHD-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-17
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-21
First Submit QC Date:
July 21 2015
Study First Post Date:
2015-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-03-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-07
Last Update Post Date:
2019-03-22
Last Update Post Date Type:
ACTUAL